Patni B, Bhattacharyya M, Pokhriyal A, Pandey D
Planta. 2025; 261(4):89.
PMID: 40089556
DOI: 10.1007/s00425-025-04647-8.
Jin X, Wu X, Li Z, Hu Y, Xia L, Zu S
Virulence. 2024; 15(1):2407847.
PMID: 39368071
PMC: 11457627.
DOI: 10.1080/21505594.2024.2407847.
Drzymala A
Int J Mol Sci. 2024; 25(17).
PMID: 39273582
PMC: 11394807.
DOI: 10.3390/ijms25179635.
Elste J, Saini A, Mejia-Alvarez R, Mejia A, Millan-Pacheco C, Swanson-Mungerson M
Biomolecules. 2024; 14(8).
PMID: 39199298
PMC: 11352483.
DOI: 10.3390/biom14080911.
Marrone L, Romano S, Albanese M, Giordano S, Morello A, Cimmino M
Heliyon. 2024; 10(15):e35341.
PMID: 39170431
PMC: 11336627.
DOI: 10.1016/j.heliyon.2024.e35341.
A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication.
Tuttolomondo M, Pham S, Terp M, Castillo V, Kalisi N, Vogel S
Mol Ther Nucleic Acids. 2024; 35(3):102227.
PMID: 38939051
PMC: 11203390.
DOI: 10.1016/j.omtn.2024.102227.
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic.
Lal A, Foong Y, Sanfilippo P, Spelman T, Rath L, Levitz D
J Neurol. 2024; 271(9):5813-5824.
PMID: 38935148
PMC: 11377668.
DOI: 10.1007/s00415-024-12518-7.
COVID-19: Unveiling the Neuropsychiatric Maze-From Acute to Long-Term Manifestations.
Ariza D, Castellar-Visbal L, Marquina M, Rivera-Porras D, Galban N, Santeliz R
Biomedicines. 2024; 12(6).
PMID: 38927354
PMC: 11200893.
DOI: 10.3390/biomedicines12061147.
Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update.
Jahandar-Lashaki S, Farajnia S, Faraji-Barhagh A, Hosseini Z, Bakhtiyari N, Rahbarnia L
Mol Biotechnol. 2024; .
PMID: 38822912
DOI: 10.1007/s12033-024-01195-6.
Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.
Tang X, Liu Y, Wang J, Long T, Yee Mok B, Huang Y
J Biol Chem. 2024; 300(6):107390.
PMID: 38777146
PMC: 11237930.
DOI: 10.1016/j.jbc.2024.107390.
Co-Expression of Niemann-Pick Type C1-Like1 (NPC1L1) with ACE2 Receptor Synergistically Enhances SARS-CoV-2 Entry and Fusion.
Elste J, Cast N, Udawatte S, Adhikari K, Payen S, Verma S
Biomedicines. 2024; 12(4).
PMID: 38672177
PMC: 11048565.
DOI: 10.3390/biomedicines12040821.
Natural medicinal plant products as an immune-boosters: A possible role to lessen the impact of Covid-19.
Islam S, Midya S, Sinha S, Saadi S
Case Stud Chem Environ Eng. 2024; 4:100105.
PMID: 38620656
PMC: 8096520.
DOI: 10.1016/j.cscee.2021.100105.
SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors.
Behboudi E, Nooreddin Faraji S, Daryabor G, Hashemi S, Asadi M, Edalat F
Heliyon. 2024; 10(4):e26577.
PMID: 38420467
PMC: 10901034.
DOI: 10.1016/j.heliyon.2024.e26577.
Integrin αβ contributes to cell fusion and inflammation mediated by SARS-CoV-2 spike via RGD-independent interaction.
Zhang H, Wang Z, Nguyen H, Watson A, Lao Q, Li A
Proc Natl Acad Sci U S A. 2023; 120(50):e2311913120.
PMID: 38060559
PMC: 10723138.
DOI: 10.1073/pnas.2311913120.
Cryo-electron microscopy in the fight against COVID-19-mechanism of virus entry.
Bodakuntla S, Kuhn C, Biertumpfel C, Mizuno N
Front Mol Biosci. 2023; 10:1252529.
PMID: 37867557
PMC: 10587472.
DOI: 10.3389/fmolb.2023.1252529.
Small Molecules against Metastatic Tumors: Concrete Perspectives and Shattered Dreams.
Serra M, Rubes D, Schinelli S, Paolillo M
Cancers (Basel). 2023; 15(16).
PMID: 37627201
PMC: 10453213.
DOI: 10.3390/cancers15164173.
Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition.
Pi P, Zeng Z, Zeng L, Han B, Bai X, Xu S
Front Pharmacol. 2023; 14:1218059.
PMID: 37601070
PMC: 10436482.
DOI: 10.3389/fphar.2023.1218059.
The Transcriptome Landscape of the In Vitro Human Airway Epithelium Response to SARS-CoV-2.
Assou S, Ahmed E, Morichon L, Nasri A, Foisset F, Bourdais C
Int J Mol Sci. 2023; 24(15).
PMID: 37569398
PMC: 10418806.
DOI: 10.3390/ijms241512017.
Are the integrin binding motifs within SARS CoV-2 spike protein and MHC class II alleles playing the key role in COVID-19?.
Gerencer M, McGuffin L
Front Immunol. 2023; 14:1177691.
PMID: 37492575
PMC: 10364474.
DOI: 10.3389/fimmu.2023.1177691.
SuPAR mediates viral response proteinuria by rapidly changing podocyte function.
Wei C, Datta P, Siegerist F, Li J, Yashwanth S, Koh K
Nat Commun. 2023; 14(1):4414.
PMID: 37479685
PMC: 10362037.
DOI: 10.1038/s41467-023-40165-5.